Neuroprotective Effect of Platinum Nanoparticles Is Not Associated with Their Accumulation in the Brain of Rats
Source abstract
Abstract
Platinum nanoparticles (nPts) have neuroprotective/antioxidant properties, but the mechanisms of their action in cerebrovascular disease remain unclear. We investigated the brain bioavailability of nPts and their effects on brain damage, cerebral blood flow (CBF), and development of brain and systemic oxidative stress (OS) in a model of cerebral ischemia (hemorrhage + temporary bilateral common carotid artery occlusion, tBCAO) in rats. The nPts (0.04 g/L, 3 ± 1 nm diameter) were administered to rats (N = 19) intraperitoneally at the start of blood reperfusion. Measurement of CBF via laser Doppler flowmetry revealed that the nPts caused a rapid attenuation of postischemic hypoperfusion. The nPts attenuated the apoptosis of hippocampal neurons, the decrease in reduced aminothiols level in plasma, and the glutathione redox status in the brain, which were induced by tBCAO. The content of Pt in the brain was extremely low (≤1 ng/g). Thus, nPts, despite the extremely low brain bioavailability, can attenuate the development of brain OS, CBF dysregulation, and neuronal apoptosis. This may indicate that the neuroprotective effects of nPts are due to indirect mechanisms rather than direct activity in the brain tissue. Research on such mechanisms may offer a promising trend in the treatment of acute disorders of CBF.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Advanced Nanomaterials in Catalysis · Neuroinflammation and Neurodegeneration Mechanisms · Neurological Disease Mechanisms and Treatments
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Institute of General Pathology and Pathophysiology, Baltiyskaya St., 8, 125315 Moscow, Russia
Russian Medical Academy for Continuing Professional Education, Barricadnaya St., 2/1 b. 1, 125993 Moscow, Russia
Institute of Microelectronic Technology and Ultra-High-Purity Materials, Akademika Osip’yana Str., 6, 142432 Chernogolovka, Russia
References (72)
Show source-provided references
1. Prevention of stroke: A global perspective10.1016/S0140-6736(18)31269-8 ↗
2. Cerebral Blood Flow Autoregulation and Dysautoregulation10.1016/j.anclin.2016.04.002 ↗
3. Cerebral Haemodynamics following Acute Ischaemic Stroke: Effects of Stroke Severity and Stroke Subtype10.1159/000487514 ↗
4. Relation of postischemic delayed hypoperfusion and cerebral edema after transient forebrain ischemia10.1016/j.jstrokecerebrovasdis.2006.12.001 ↗
5. Hasan, T.F., Hasan, H., and Kelley, R.E. (2021). Overview of Acute Ischemic Stroke Evaluation and Management. Biomedicines, 9.10.3390/biomedicines9101486 ↗
6. Neuroprotection in Acute Ischemic Stroke: A Battle Against the Biology of Nature10.3389/fneur.2022.870141 ↗
7. b1-blockers lower norepinephrine release by inhibiting presynaptic, facilitating b1-adrenoceptors in normotensive and hypertensive rats10.3389/fneur.2014.00051 ↗
8. Endothelial dysfunction in rat mesenteric resistance artery after transient middle cerebral artery occlusion10.1124/jpet.107.134619 ↗
9. Jelinek, M., Jurajda, M., and Duris, K. (2021). Oxidative Stress in the Brain: Basic Concepts and Treatment Strategies in Stroke. Antioxidants, 10.10.3390/antiox10121886 ↗
10. Oxidative Stress-Induced Endothelial Dysfunction in Cardiovascular Diseases10.31083/j.fbl2703105 ↗
11. Traumatic brain injury-induced autoregulatory dysfunction and spreading depression-related neurovascular uncoupling: Pathomecha-nisms, perspectives, and therapeutic implications10.1152/ajpheart.00267.2016 ↗
12. Edaravone for acute ischemic stroke—Systematic review with meta-analysis10.1016/j.clineuro.2022.107299 ↗
13. Evidence for a Beneficial Effect of Oral N-acetylcysteine on Functional Outcomes and Inflammatory Biomarkers in Patients with Acute Ischemic Stroke10.2147/NDT.S241497 ↗
14. Nanoparticle-Based Therapeutics for Brain Injury10.1002/adhm.201700668 ↗
15. Nanoparticles-mediated emerging approaches for effective treatment of ischemic stroke10.1016/j.biomaterials.2021.121111 ↗
16. Platinum nanoparticles in nanobiomedicine10.1039/C7CS00152E ↗
17. Kinetic analysis of superoxide anion radical-scavenging and hydroxyl radical-scavenging activities of platinum nanoparticles10.1021/la704046f ↗
18. Direct evidence for catalase and peroxidase activities of ferritin-platinum nanoparticles10.1016/j.biomaterials.2010.11.004 ↗
19. Plasma low-molecular-weight thiol/disulphide homeostasis as an early indicator of global and focal cerebral ischaemia10.1080/13510002.2017.1311464 ↗
20. Metoprolol and Nebivolol Prevent the Decline of the Redox Status of Low-Molecular-Weight Aminothiols in Blood Plasma of Rats During Acute Cerebral Ischemia10.1097/FJC.0000000000000616 ↗
21. Impact of glutathione on acute ischemic stroke severity and outcome: Possible role of aminothiols redox status10.1080/13510002.2021.1952819 ↗
22. Kesidou, E., Bitsina, C., Chatzisotiriou, A., Theotokis, P., Dandi, E., Tata, D.A., and Spandou, E. (2022). N-Acetylcysteine Administration Attenuates Sensorimotor Impairments Following Neonatal Hypoxic-Ischemic Brain Injury in Rats. Int. J. Mol. Sci., 23.10.3390/ijms232416175 ↗
23. Neuroprotective effects of N-acetylcysteine via inhibition of matrix metalloproteinase in a mouse model of transient global cerebral ischemia10.1016/j.brainresbull.2019.10.004 ↗
24. Liu, S., Tao, J., Duan, F., Li, H., and Tan, H. (2022). HHcy Induces Pyroptosis and Atherosclerosis via the Lipid Raft-Mediated NOX-ROS-NLRP3 Inflammasome Pathway in apoE−/− Mice. Cells, 11.10.3390/cells11152438 ↗
25. The role of B vitamins in stroke prevention10.1080/10408398.2021.1885341 ↗
26. Cellular uptake of platinum nanoparticles in human colon carcinoma cells and their impact on cellular redox systems and DNA integrity10.1021/tx800354g ↗
27. Epigenetic Regulations of Microglia/Macrophage Polarization in Ischemic Stroke10.3389/fnmol.2021.697416 ↗
28. S-adenosylhomocysteine catabolism and basis for acquired resistance during treatment of T-cell acute lymphoblastic leukemia with 2-deoxycoformycin alone and in combination with 9-beta-D-arabinofuranosyladenine
29. S-adenosyl-L-methionine prevents ischemic neuronal death10.1016/0014-2999(87)90521-8 ↗
30. S-adenosyl-L-methionine protects the hippocampal CA1 neurons from the ischemic neuronal death in rat10.1016/0006-291X(88)90547-5 ↗
31. Epigenetic signature of chronic cerebral hypoperfusion and beneficial effects of S-adenosylmethionine in rats10.1007/s12035-014-8698-5 ↗
32. Effects of S-adenosyl-L-methionine on lipid peroxidation and glutathione levels in rat brain slices exposed to reoxygenation after oxygen-glucose deprivation10.1016/S0304-3940(01)02475-2 ↗
33. Neurological and pathological improvements of cerebral infarction in mice with platinum nanoparticles10.1002/jnr.22622 ↗
34. Strong neuroprotection with a novel platinum nanoparticle against ischemic stroke- and tissue plasminogen activator-related brain damages in mice10.1016/j.neuroscience.2012.06.060 ↗
35. The blood-brain barrier in health and disease: Important unanswered questions10.1084/jem.20190062 ↗
36. Crossing the blood-brain barrier with nanoparticles10.1016/j.jconrel.2017.12.015 ↗
37. Application of wavelet analysis to detect dysfunction in cerebral blood flow autoregulation during experimental hyperhomocysteinaemia10.1007/s10103-018-2485-x ↗
38. Sandell, E.B. (1959). Colorimetric Determination of Traces of Metals, Interselenct Publishers Inc.
39. Use of the Inductively Coupled Plasma Mass Spectrometry for Element Analysis of Environmental Objects10.1134/S0020168508140045 ↗
40. An Experimental Study of the Pharmacokinetics of the Antitumor Drug Aurumacryl10.1134/S0006350918030181 ↗
41. Paxinos, G., and Watson, C. (2007). The Rat Brain in Stereotaxic Coordinates, Elsevier. [6th ed.].
42. Regional brain blood flow, blood volume, and haematocrit values in the adult rat10.1038/jcbfm.1983.35 ↗
43. Blood Density Is Nearly Equal to Water Density: A Validation Study of the Gravimetric Method of Measuring Intraoperative Blood Loss10.1155/2015/152730 ↗
44. Platinum-Based Nanostructured Materials: Synthesis, Properties, and Applications10.1021/cr9003902 ↗
45. Optimized reduction conditions for the microfluidic synthesis of 1.3–0.3 nm Pt clusters10.1007/s40097-015-0179-5 ↗
46. Ischemic preconditioning reduces peripheral oxidative damage associated with brain ischemia in rats10.1590/S0100-879X1999001000017 ↗
47. Neuroprotective effects of carvedilol, a new antihypertensive agent, in cultured rat cerebellar neurons and in gerbil global brain ischemia10.1161/01.STR.23.11.1630 ↗
48. Influ-ence of carvedilol on the redox-status of low-molecular-weight aminothyols in blood plasma during acute cerebral ischemia inrats
49. Antioxidant N-acetylcysteine inhibits the activation of JNK3 mediated by the GluR6-PSD95-MLK3 signaling module during cerebral ischemia in rat hippocampus10.1016/j.neulet.2006.07.007 ↗
50. Cerebral Perfusion and Cerebral Autoregulation after Cardiac Arrest
51. Traumatic Brain Injury Causes Endothelial Dysfunction in the Systemic Microcirculation through Arginase-1-Dependent Uncoupling of Endothelial Nitric Oxide Synthase10.1089/neu.2015.4340 ↗
52. Gene transfer of Cu/Zn SOD to cerebral vessels prevents FPI-induced CBF autoregulatory dysfunction10.1152/ajpheart.00590.2001 ↗
53. Peroxynitrite reversibly inhibits Ca2+-activated K+ channels in rat cerebral artery smooth muscle cells10.1152/ajpheart.2000.278.6.H1883 ↗
54. Platinum nanoparticles: An avenue for enhancing the release of nitric oxide from S-nitroso-N-acetylpenicillamine and S-nitrosoglutathione10.1039/C8NR03874K ↗
55. Platinum nanoparticles Protect Against Lipopolysaccharide-Induced Inflammation in Microglial BV-2 Cells via Decreased Oxidative Damage and Increased Phagocytosis10.1007/s11064-021-03434-7 ↗
56. Different Cellular Effects of Platinum Nanoparticles on RAW 264.7 Cells10.1166/jnn.2019.15912 ↗
57. Hypermetabolism following moderate to severe traumatic acute brain injury: A systematic review10.1089/neu.2008.0628 ↗
58. Why is the neural control of cerebral autoregulation so controversial?10.12703/P6-14 ↗
59. Sympathetic regulation of cerebral blood flow in humans: A review10.1093/bja/aet122 ↗
60. The role of spreading depression, spreading depolarization and spreading ischemia in neurological disease10.1038/nm.2333 ↗
61. Rodent models of global cerebral ischemia: A comparison of two-vessel occlusion and four-vessel occlusion10.1016/S0306-3623(97)00284-X ↗
62. Co-existence of necrosis and apoptosis in rat hippocampus following transient forebrain ischemia10.1016/S0168-0102(00)00107-3 ↗
63. Alterations of hippocampal postsynaptic densities following transient ischemia10.1002/1098-1063(2000)10:5<610::AID-HIPO12>3.0.CO;2-E ↗
64. Tumor delivery of macromolecular drugs based on the EPR effect10.1016/j.addr.2010.03.011 ↗
65. Platinum nanoparticle antioxidants inhibit pulmonary inflammation in mice exposed to cigarette smoke10.1016/j.pupt.2008.12.015 ↗
66. Reducing stress on cells with apoferritin-encapsulated platinum nanoparticles10.1021/nl903313r ↗
67. Nejdl, L., Kudr, J., Moulick, A., Hegerova, D., Ruttkay-Nedecky, B., Gumulec, J., Cihalova, K., Smerkova, K., Dostalova, S., and Krizkova, S. (2017). Platinum nanoparticles induce damage to DNA and inhibit DNA replication. PLoS ONE, 12.10.1371/journal.pone.0180798 ↗
68. Anticancer Properties of Platinum Nanoparticles and Retinoic Acid: Combination Therapy for the Treatment of Human Neuroblastoma Cancer10.3390/ijms21186792 ↗
69. Biocompatibility of Platinum Nanoparticles in Brain ex vivo Models in Physiological and Pathological Conditions10.3389/fnins.2021.787518 ↗
70. Platinum nanoparticles: Efficient and stable catechol oxidase mimetics10.1021/acsami.5b05180 ↗
71. Colorimetric assay of heparin in plasma based on the inhibition of oxidase-like activity of citrate-capped platinum nanoparticles10.1016/j.bios.2016.10.082 ↗
72. The acute toxic effects of platinum nanoparticles on ion channels, transmembrane potentials of cardiomyocytes in vitro and heart rhythm in vivo in mice10.2147/IJN.S209135 ↗